As Gen Zs and millennials rethink the role of work in their lives, work/life balance remains a top priority with flexible work arrangements, including part-time jobs growing in popularity Gen Zs and millennials cite the cost of living as their top societal concern, with more than half of respondents saying they live paycheck to paycheck … Read more
DUBLIN, May 17, 2023 /PRNewswire/ — The “Surgical Procedures Market by Surgery Type – Global Opportunity Analysis and Industry Forecast, 2023-2030” report has been added to ResearchAndMarkets.com’s offering. The Surgical Procedures Market size was 294,237 thousand units in 2022, and is predicted to reach 372,837 thousand units by 2030, with a CAGR of 3.1% from 2023 … Read more
Beweisbasierte Empfehlungen unterstützen den wirksamen Einsatz von TOT bei der Behandlung von diabetischen Fußgeschwüren und revolutionieren die Behandlungsansätze weltweit CAMBRIDGE, England, 17. Mai 2023 /PRNewswire/ — NATROX® Wound Care, ein führender Innovator auf dem Gebiet der Wundversorgungstechnologie, gibt mit Stolz die Veröffentlichung neuer Expertenempfehlungen für den Einsatz der topischen Sauerstofftherapie zur Wundheilung bekannt1. Die aktualisierten … Read more
SAN FRANCISCO, May 17, 2023 /PRNewswire/ — The global cleanroom technology market size is expected to reach USD 5.6 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.58% from 2023 to 2030. Growing compliance with stringent regulatory standards for new product … Read more
Uniting to Combat Neglected Tropical Diseases (unitingtocombatntds.org) releases letter signed by 36 Parliamentarians from 23 countries calling on G7 Leaders to invest in NTDs. LONDON, May 17, 2023 /PRNewswire/ — To: Fumio Kishida, Prime Minister, Japan (Host) Joe Biden, President, United StatesEmmanuel Macron, President, FranceGiorgia Meloni, Prime Minister, ItalyOlaf Scholz, Chancellor, GermanyRishi Sunak, Prime Minister, … Read more
LUND, Sweden, May 17, 2023 /PRNewswire/ — Immunovia will publish its first quarter 2023 results on May 23, 2023 at 8:30 am CET. Analysts, investors and media are invited to a webcast teleconference on the same day at 15:00 CET. The report together with the presentation slides will be available at www.immunovia.com Jeff Borcherding, CEO … Read more
LUND, Sweden, May 17, 2023 /PRNewswire/ — Immunovia will publish its first quarter 2023 results on May 23, 2023 at 8:30 am CET. Analysts, investors and media are invited to a webcast teleconference on the same day at 15:00 CET. The report together with the presentation slides will be available at www.immunovia.com Jeff Borcherding, CEO … Read more
PARIS, May 17, 2023 /PRNewswire/ — Edwards Lifesciences (NYSE: EW) announced today that new data from the Benchmark Registry in Europe demonstrated the safety and effectiveness of this streamlined treatment pathway for patients receiving transcatheter aortic valve replacement (TAVR) with balloon-expandable valves. The data were presented in a late-breaking clinical data session at EuroPCR 2023. … Read more
Cell therapy, RNA technology, antibody drug conjugates and AI/machine learning among key areas of investment for pharma LONDON, May 17, 2023 /PRNewswire/ — Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released its new report, Biopharma Dealmaking in 2023. This year’s report … Read more
Cell therapy, RNA technology, antibody drug conjugates and AI/machine learning among key areas of investment for pharma LONDON, May 17, 2023 /PRNewswire/ — Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released its new report, Biopharma Dealmaking in 2023. This year’s report … Read more